Article Information
vol. 9 no. 413
- Received for publication July 27, 2017
- Accepted for publication September 22, 2017
- .
Author Information
- Evangelos D. Michelakis1,*,
- Vikram Gurtu1,
- Linda Webster1,
- Gareth Barnes2,
- Geoffrey Watson2,
- Luke Howard3,
- John Cupitt2,
- Ian Paterson1,
- Richard B. Thompson4,
- Kelvin Chow4,
- Declan P. O’Regan5,
- Lan Zhao2,
- John Wharton2,
- David G. Kiely6,
- Adam Kinnaird1,
- Aristeidis E. Boukouris1,
- Chris White7,
- Jayan Nagendran7,
- Darren H. Freed7,
- Stephen J. Wort8,
- J. Simon R. Gibbs3 and
- Martin R. Wilkins2,*
- 1Department of Medicine, University of Alberta, Edmonton, Alberta T6G2B7, Canada.
- 2Department of Medicine, Imperial College London, London W12 0NN, UK.
- 3National Pulmonary Hypertension Service, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
- 4Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta T6G2B7, Canada.
- 5Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital Campus, Imperial College London, London W12 0NN, UK.
- 6Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield S10 2JF, UK.
- 7Department of Surgery, University of Alberta, Edmonton, Alberta T6G2B7, Canada.
- 8National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK.
- ↵*Corresponding author. Email: em2{at}ualberta.ca (E.D.M.); m.wilkins{at}imperial.ac.uk (M.R.W.)